The End of Silicon Valley as We Know It?
Exscientia Files For $100M IPO
Major venture capital investment in European life sciences will fuel occupier market
Cambridge-1 and the future of medicine
Investment Into Biosciences Boomed, Could The Bubble Burst?
How data is helping European VCs find their next hidden gems
Fund commits to $350M dedicated LS investments
Family Offices Become Serious Rivals to VC Firms
Alphabet's VC Arm adds Senior Healthcare Partner
ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding
3 Myths About Women Working in Tech, Busted
Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus